Limitations in FABP4 as a biomarker for diabetic nephropathy: a critique of Shaker et al.
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-04-01
|
Series: | The Egyptian Journal of Internal Medicine |
Online Access: | https://doi.org/10.1186/s43162-023-00216-1 |